Versor Investments LP lessened its stake in shares of Houlihan Lokey, Inc. (NYSE:HLI - Free Report) by 57.2% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,000 shares of the financial services provider's stock after selling 2,671 shares during the quarter. Versor Investments LP's holdings in Houlihan Lokey were worth $323,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Alliance Wealth Advisors LLC UT bought a new stake in shares of Houlihan Lokey during the first quarter worth $335,000. Ethic Inc. grew its stake in shares of Houlihan Lokey by 4.2% during the first quarter. Ethic Inc. now owns 4,989 shares of the financial services provider's stock worth $819,000 after buying an additional 203 shares during the last quarter. OneAscent Investment Solutions LLC bought a new stake in shares of Houlihan Lokey during the first quarter worth $511,000. Vestmark Advisory Solutions Inc. grew its stake in shares of Houlihan Lokey by 76.3% during the first quarter. Vestmark Advisory Solutions Inc. now owns 2,494 shares of the financial services provider's stock worth $403,000 after buying an additional 1,079 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its stake in shares of Houlihan Lokey by 3,714.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 267 shares of the financial services provider's stock worth $43,000 after buying an additional 260 shares during the last quarter. Institutional investors own 78.07% of the company's stock.
Houlihan Lokey Trading Up 1.6%
HLI stock traded up $3.13 during midday trading on Tuesday, hitting $199.48. The stock had a trading volume of 174,460 shares, compared to its average volume of 401,212. The firm has a market cap of $14.03 billion, a P/E ratio of 33.58 and a beta of 0.86. Houlihan Lokey, Inc. has a 1-year low of $137.99 and a 1-year high of $199.75. The business has a fifty day moving average price of $188.81 and a two-hundred day moving average price of $174.11.
Houlihan Lokey (NYSE:HLI - Get Free Report) last released its earnings results on Tuesday, July 29th. The financial services provider reported $2.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.69 by $0.45. Houlihan Lokey had a net margin of 16.46% and a return on equity of 23.75%. The business had revenue of $605.35 million for the quarter, compared to analyst estimates of $573.07 million. During the same quarter in the previous year, the business earned $1.22 earnings per share. Houlihan Lokey's revenue for the quarter was up 17.8% on a year-over-year basis. On average, equities analysts anticipate that Houlihan Lokey, Inc. will post 5.98 EPS for the current year.
Houlihan Lokey Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Tuesday, September 2nd will be issued a dividend of $0.60 per share. The ex-dividend date is Tuesday, September 2nd. This represents a $2.40 annualized dividend and a dividend yield of 1.2%. Houlihan Lokey's dividend payout ratio is currently 40.40%.
Insider Activity
In other news, Chairman Irwin Gold sold 5,000 shares of the company's stock in a transaction dated Monday, June 30th. The shares were sold at an average price of $182.81, for a total transaction of $914,050.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, General Counsel Christopher M. Crain sold 500 shares of the company's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $173.02, for a total transaction of $86,510.00. The disclosure for this sale can be found here. 22.83% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
A number of research firms have weighed in on HLI. Morgan Stanley reaffirmed an "overweight" rating and set a $192.00 target price (up previously from $159.00) on shares of Houlihan Lokey in a research note on Monday, June 23rd. Wells Fargo & Company boosted their price objective on shares of Houlihan Lokey from $185.00 to $209.00 and gave the stock an "overweight" rating in a research note on Friday, July 11th. Wall Street Zen cut shares of Houlihan Lokey from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Finally, Keefe, Bruyette & Woods raised shares of Houlihan Lokey from a "hold" rating to a "moderate buy" rating and boosted their price objective for the stock from $185.00 to $232.00 in a research note on Monday, July 14th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $206.40.
Check Out Our Latest Research Report on Houlihan Lokey
Houlihan Lokey Profile
(
Free Report)
Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.
Further Reading

Before you consider Houlihan Lokey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Houlihan Lokey wasn't on the list.
While Houlihan Lokey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.